Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
BUPRENORPHINE HYDROCHLORIDE INJECTIONPharmacy times, 2020-07, Vol.86 (7), p.48COPYRIGHT 2020 Pharmacy & Healthcare Communications, LLC ;ISSN: 0003-0627 ;EISSN: 2168-7234Full text available |
|
2 |
Material Type: Article
|
Buprenorphine Pharmacology Review: Update on Transmucosal and Long-acting FormulationsJournal of addiction medicine, 2019-03, Vol.13 (2), p.93EISSN: 1935-3227 ;DOI: 10.1097/ADM.0000000000000457 ;PMID: 30531584Digital Resources/Online E-Resources |
|
3 |
Material Type: Article
|
Extended-release versus oral buprenorphine as opioid maintenance treatment during pregnancy-maternal and neonatal outcomesEuropean journal of obstetrics & gynecology and reproductive biology, 2024-06, Vol.297, p.106 [Peer Reviewed Journal]Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved. ;EISSN: 1872-7654 ;DOI: 10.1016/j.ejogrb.2024.04.003 ;PMID: 38608352Digital Resources/Online E-Resources |
|
4 |
Material Type: Article
|
A Comparison of Buprenorphine, Sustained release Buprenorphine, and High concentration Buprenorphine in Male New Zealand White RabbitsJournal of the American Association for Laboratory Animal Science, 2020-09, Vol.59 (5), p.546-556 [Peer Reviewed Journal]American Association for Laboratory Animal Science 2020 ;ISSN: 1559-6109 ;EISSN: 2769-6677 ;DOI: 10.30802/AALAS-JAALAS-19-000132 ;PMID: 32674750Full text available |
|
5 |
Material Type: Article
|
The Pharmacokinetics and Pharmacodynamics of Buprenorphine in Neonatal Abstinence SyndromeClinical pharmacology and therapeutics, 2018-06, Vol.103 (6), p.1029 [Peer Reviewed Journal]2018 American Society for Clinical Pharmacology and Therapeutics. ;EISSN: 1532-6535 ;DOI: 10.1002/cpt.1064 ;PMID: 29516490Digital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
The switching process from buprenorphine sublingual tablets to the monthly buprenorphine subcutaneous depot injection in opioid dependent patientsAddiction biology, 2023-05, Vol.28 (5), p.e13275-n/a [Peer Reviewed Journal]2023 The Authors. published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction. ;2023 The Authors. Addiction Biology published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction. ;2023. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1355-6215 ;EISSN: 1369-1600 ;DOI: 10.1111/adb.13275 ;PMID: 37186443Digital Resources/Online E-Resources |
|
7 |
Material Type: Article
|
Rotating palliative care patients from full agonist opioids to low dose milligram buprenorphineJournal of pain and symptom management, 2024-05 [Peer Reviewed Journal]2024 ;ISSN: 0885-3924 ;EISSN: 1873-6513 ;DOI: 10.1016/j.jpainsymman.2024.05.018 ;PMID: 38777074Digital Resources/Online E-Resources |
|
8 |
Material Type: Article
|
Buprenorphine physician–pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials NetworkAddiction (Abingdon, England), 2021-07, Vol.116 (7), p.1805-1816 [Peer Reviewed Journal]2021 Society for the Study of Addiction ;2021 Society for the Study of Addiction. ;ISSN: 0965-2140 ;EISSN: 1360-0443 ;DOI: 10.1111/add.15353 ;PMID: 33428284Digital Resources/Online E-Resources |
|
9 |
Material Type: Article
|
No Clinically Relevant Drug-Drug Interactions between Methadone or Buprenorphine-Naloxone and Antiviral Combination Glecaprevir and PibrentasvirAntimicrobial agents and chemotherapy, 2017-10, Vol.61 (10) [Peer Reviewed Journal]Copyright © 2017 American Society for Microbiology. ;Copyright © 2017 American Society for Microbiology. 2017 American Society for Microbiology ;ISSN: 0066-4804 ;EISSN: 1098-6596 ;DOI: 10.1128/AAC.00958-17 ;PMID: 28807904Full text available |
|
10 |
Material Type: Article
|
Interactions Between Buprenorphine and the Protease Inhibitors Darunavir-Ritonavir and Fosamprenavir-RitonavirClinical infectious diseases, 2012-02, Vol.54 (3), p.414-423 [Peer Reviewed Journal]Copyright © 2012 Oxford University Press on behalf of the Infectious Diseases Society of America ;The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. 2012 ;2015 INIST-CNRS ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/cir799 ;PMID: 22100576 ;CODEN: CIDIELFull text available |
|
11 |
Material Type: Article
|
Buprenorphine–Naloxone Therapy in Pain ManagementAnesthesiology (Philadelphia), 2014-05, Vol.120 (5), p.1262-1274 [Peer Reviewed Journal]2014 American Society of Anesthesiologists, Inc. ;2015 INIST-CNRS ;ISSN: 0003-3022 ;EISSN: 1528-1175 ;DOI: 10.1097/ALN.0000000000000170 ;PMID: 24509068 ;CODEN: ANESAVFull text available |
|
12 |
Material Type: Article
|
Buprenorphine for managing opioid withdrawalCochrane database of systematic reviews, 2017-02, Vol.2017 (2), p.CD002025 [Peer Reviewed Journal]Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD002025.pub5 ;PMID: 28220474Full text available |
|
13 |
Material Type: Article
|
Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorderActa obstetricia et gynecologica Scandinavica, 2023-03, Vol.102 (3), p.313-322 [Peer Reviewed Journal]2022 The Authors. published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG). ;2022 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG). ;2022. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0001-6349 ;EISSN: 1600-0412 ;DOI: 10.1111/aogs.14497 ;PMID: 36562462Full text available |
|
14 |
Material Type: Article
|
The Efficacy of Buprenorphine in Major Depression, Treatment-Resistant Depression and Suicidal Behavior: A Systematic ReviewInternational journal of molecular sciences, 2018-08, Vol.19 (8), p.2410 [Peer Reviewed Journal]2018. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 by the authors. 2018 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms19082410 ;PMID: 30111745Full text available |
|
15 |
Material Type: Article
|
Perceptions of extended‐release buprenorphine injections for opioid use disorder among people who regularly use opioids in AustraliaAddiction (Abingdon, England), 2020-07, Vol.115 (7), p.1295-1305 [Peer Reviewed Journal]2019 The Authors. published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction ;2019 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction. ;2019. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0965-2140 ;EISSN: 1360-0443 ;DOI: 10.1111/add.14941 ;PMID: 31860767Digital Resources/Online E-Resources |
|
16 |
Material Type: Article
|
Treating Chronic Pain: An Overview of Clinical Studies Centered on the Buprenorphine OptionDrugs (New York, N.Y.), 2018-08, Vol.78 (12), p.1211-1228 [Peer Reviewed Journal]Springer Nature Switzerland AG 2018 ;Copyright Springer Nature B.V. Aug 2018 ;ISSN: 0012-6667 ;EISSN: 1179-1950 ;DOI: 10.1007/s40265-018-0953-z ;PMID: 30051169Full text available |
|
17 |
Material Type: Article
|
Characterizing acute and postsurgical pain management in patients receiving buprenorphine or buprenorphine/naloxoneJournal of the American Pharmacists Association, 2024-05, Vol.64 (3), p.102035 [Peer Reviewed Journal]Published by Elsevier Inc. ;EISSN: 1544-3450 ;DOI: 10.1016/j.japh.2024.02.008 ;PMID: 38364887Digital Resources/Online E-Resources |
|
18 |
Material Type: Article
|
Factors Affecting Buprenorphine Utilization and Spending in Medicaid, 2002-2018Value in health, 2021-02, Vol.24 (2), p.182 [Peer Reviewed Journal]Copyright © 2020 ISPOR–The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved. ;EISSN: 1524-4733 ;DOI: 10.1016/j.jval.2020.04.1840 ;PMID: 33518024Digital Resources/Online E-Resources |
|
19 |
Material Type: Article
|
On my own terms: Motivations for self-treating opioid-use disorder with non-prescribed buprenorphineDrug and alcohol dependence, 2020-05, Vol.210, p.107958 [Peer Reviewed Journal]Copyright © 2020 Elsevier B.V. All rights reserved. ;EISSN: 1879-0046 ;DOI: 10.1016/j.drugalcdep.2020.107958 ;PMID: 32203863Digital Resources/Online E-Resources |
|
20 |
Material Type: Article
|
A randomised controlled trial of sublingual buprenorphine-naloxone film versus tablets in the management of opioid dependenceDrug and alcohol dependence, 2013-07, Vol.131 (1-2), p.119 [Peer Reviewed Journal]Copyright © 2013 Elsevier Ireland Ltd. All rights reserved. ;EISSN: 1879-0046 ;DOI: 10.1016/j.drugalcdep.2012.12.009 ;PMID: 23317685Digital Resources/Online E-Resources |